Companion Diagnostics Market to Witness Steady Growth at 32.3% CAGR During 2016 – 2021

Researchmoz added Most up-to-date research on “Companion Diagnostics: Technologies and Markets” to its huge collection of research reports.

Report Highlights
The global market for companion diagnostics reached nearly $3.2 billion in 2015. This market is expected to increase from $4.3 billion in 2016 to nearly $17.6 billion in 2021 at a compound annual growth rate (CAGR) of 32.3% for 2016-2021.

Report Includes

An overview of the market for companion diagnostics, including existing products on the market and detailed analysis of the competitive environments.
Analyses of market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Examination of the current state of the industry, new technologies in assay development, and potential novel commercial venues in this area of the healthcare industry.
Identification of major commercial sectors in companion diagnostics: oncology related products vs. cardiovascular diseases and other segments.
Profiles of major players as well as a list of current companies that have new companion diagnostics products in development.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377117

Report Scope

The scope of the report encompasses the major types of diagnostics technologies that have been used, the various industry structures such as the lab developed tests (LDTs) sector, and the major applications being commercialized and developed by a wide range of company types. It analyzes current market status, examines future market drivers and presents forecasts of growth over the next five years. Technology developments, including the latest trends, are discussed.

Chapter 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST’S CREDENTIALS
RELATED REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
Chapter 2 SUMMARY
Chapter 3 PERSONALIZED MEDICINE OVERVIEW
Chapter 4 CDX APPLICATIONS OTHER THAN CANCER
Chapter 5 FDA DESIGNATED CDXCANCER
Chapter 6 CURRENT TECHNIQUES, TECHNOLOGIES AND MARKET STRUCTURES
Chapter 7 NOT FDA REQUIRED
Chapter 8 EMERGING LIQUID BIOPSY MARKET
Chapter 9 UNIVERSAL CDX
Chapter 10 FUTURE APPLICATIONS: CARDIOVASCULAR AND METABOLIC DISEASE
Chapter 11 REPRESENTATIVE ACQUISITIONS AND COMPANY PROFILES
OVERVIEW
ONCOLOGY AS MAJOR DRIVER
COMPANION DIAGNOSTICS OVERVIEW

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/companion-diagnostics-technologies-and-markets-report.html/toc

GENERAL APPLICATION CATEGORIES
FDA DEFINITION
FDA CLEARED (510K) AND APPROVED (PMA) MARKET
BEYOND “FDA DESIGNATED CDX”
PHARMACEUTICAL-DIAGNOSTIC DEALS
COMPANY TYPES
HISTORY OF COMPANION DIAGNOSTICS
REGULATORY ASPECTS
KEY COMPANIES
CANCER MARKET SEGMENT
TECHNOLOGIES OVERVIEW
REIMBURSEMENT
DRIVERS OF ADOPTION
BARRIERS TO ADOPTION
COST OF CDX DEVELOPMENT
CDX REGULATORY ISSUES
2015 PRECISION MEDICINE INITIATIVE
POTENTIAL FOR PERSONALIZED MEDICINE
Continue…

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

Follow us on LinkedIn @ http://bit.ly/1TBmnVG

Follow me on @ https://marketsizeinfo.blogspot.in/

Comments

comments

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *